<DOC>
	<DOC>NCT02180945</DOC>
	<brief_summary>The objective of this study is to evaluate the safety (at 1 month) and the performance (at 3-6 months) post last embolization with Onyx or Onyx associated with other embolization products (cyanoacrylate glue, coils, balloon, otherâ€¦)</brief_summary>
	<brief_title>ONYX Evaluation in the Endovascular Treatment of Intracranial Dural Arteriovenous Fistulae</brief_title>
	<detailed_description />
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Arteriovenous Fistula</mesh_term>
	<mesh_term>Central Nervous System Vascular Malformations</mesh_term>
	<criteria>The patient has an intracranial dAVF which could be treated by ONYX embolization, whether or not associated to other embolization products. The patient is at least 18 years of age. The patient needs to be treated for the dAVF with another treatment option (for example by surgery) than embolization within a period of less than 6 months (to be counted as from the first treatment) The patient participates to another clinical study during the treatment period for his/her dAVF, evaluating another medical devices, procedure or medication. The patient refuses to give consent to the collection and processing of data required for centralized monitoring. A condition which could jeopardize followup of the patient.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>dAVF</keyword>
	<keyword>Arteriovenous fistula</keyword>
	<keyword>ONYX</keyword>
</DOC>